STAAR Surgical Company (STAA)

NGM – Real Time Price. Currency in USD

25.41

+0.47 (1.88%)

At close: Aug 12, 2026, 4:00 PM EDT

24.89

-0.52 (-2.05%)

After-hours: Aug 12, 2026, 6:26 PM EDT

12.08.2026

STAAR Surgical Reports Second Quarter 2026 Results

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the second quarter ended July 3, 2026. Second Quarter 2026 Financial Overview Net sales of $93.5 million, up 111% Y/Y Net sales excluding China of $41.2 million, up 6.0% Y/Y China sales of $52.3 million up over 100%, 10% sequentially APAC sales up 189% Y/Y, ex-China sales up.

05.08.2026

Staar Surgical (STAA) Upgraded to Strong Buy: What Does It Mean for the Stock?

Staar Surgical (STAA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

04.08.2026

STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that following an extensive global search, its Board of Directors (the "Board") has appointed Warren Foust as President and Chief Executive Officer and a new member of the Board of Directors, effective August 4, 2026. Mr. Foust joined STAAR in April 2023 and h.

04.08.2026

STAAR Surgical to Host Second Quarter 2026 Earnings Results Call and Webcast on August 12, 2026

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results in combination with a shareholder letter for the second quarter ended July 3, 2026, on Wednesday, August 12, 2026, after the market close. The Company will also host an earnings call and webcast at 5:30 p.m. ET to discuss its financial results and.

Videos

No Data

There is no data to display

Upgrades / Downgrades

Ticker	Brokerage Firm	Ratings Change	Price Target	Date
STAA	UBS	Sell	undefined >> $20	July 28th 2026

Press releases

12.08.2026

STAAR Surgical Reports Second Quarter 2026 Results

04.08.2026

STAAR Surgical Company (STAA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

STAAR Surgical Company (STAA)

STAAR Surgical Reports Second Quarter 2026 Results

Staar Surgical (STAA) Upgraded to Strong Buy: What Does It Mean for the Stock?

STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer

STAAR Surgical to Host Second Quarter 2026 Earnings Results Call and Webcast on August 12, 2026

Videos

No Data

Upgrades / Downgrades

Press releases

STAAR Surgical Reports Second Quarter 2026 Results

STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer

STAAR Surgical Reports Second Quarter 2026 Results

Staar Surgical (STAA) Upgraded to Strong Buy: What Does It Mean for the Stock?

STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer

STAAR Surgical to Host Second Quarter 2026 Earnings Results Call and Webcast on August 12, 2026

Videos

No Data

Upgrades / Downgrades

Press releases

STAAR Surgical Reports Second Quarter 2026 Results

STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer

Search stocks

STAAR Surgical Company (STAA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

STAAR Surgical Company (STAA)

STAAR Surgical Reports Second Quarter 2026 Results

Staar Surgical (STAA) Upgraded to Strong Buy: What Does It Mean for the Stock?

STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer

STAAR Surgical to Host Second Quarter 2026 Earnings Results Call and Webcast on August 12, 2026

Videos

No Data

Upgrades / Downgrades

Press releases

STAAR Surgical Reports Second Quarter 2026 Results

STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer

STAAR Surgical Reports Second Quarter 2026 Results

Staar Surgical (STAA) Upgraded to Strong Buy: What Does It Mean for the Stock?

STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer

STAAR Surgical to Host Second Quarter 2026 Earnings Results Call and Webcast on August 12, 2026

Videos

No Data

Upgrades / Downgrades

Press releases

STAAR Surgical Reports Second Quarter 2026 Results

STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer